Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
about
Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metforminDefinition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.Differences in endocrine parameters and psychopathology in girls with premature adrenarche versus on-time adrenarcheOvarian dysfunction, stress, and disease: a primate continuum.The pathogenetic enigma of polycystic ovary syndrome.Endobiogeny: a global approach to systems biology (part 2 of 2)Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.Treatment of polycystic ovary syndrome with insulin-lowering agents.Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome.Association of polycystic ovary syndrome with cardiovascular risk factors.Effect of Implanon on insulin resistance in women with Polycystic Ovary Syndrome.Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome.Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries.
P2860
Q33663978-CC0024E1-00EA-48AB-B7D3-E36098D14936Q34031584-680B4F00-9679-41B6-B3E2-8D7224231546Q34392414-88255B69-059F-449D-8F0B-845158B1C0D3Q34800996-847E85F8-41A2-40BB-A1DE-AE29962D59FFQ35757541-258A5FA1-45D3-4A76-825F-4536F46DBCF4Q36556867-141B9BF6-B9C2-4356-8D20-ABEEE98A1DCFQ37323903-91FD76F1-2F76-47D2-A7CC-AA61D896C5C6Q37361766-6CC3A229-97D3-4C6E-9F47-32A4533CA23AQ37412812-A1DFFE70-6125-44BA-9EE4-AE84F53BC44BQ37482748-02B7CBF4-4679-4564-8428-A464C3B7E1FFQ39041432-AA44D00E-DD25-48C0-9FCC-0D968D497D70Q44084386-2219DE39-AFCE-4CE6-8B18-0DD702785612Q44718267-3B6DB3D1-0AAF-4310-A52C-3BADB06CD2F8Q45917076-38B92460-8F7A-4566-B25D-04071AE13868Q46370052-AD791E18-EF24-4B8A-9A88-7CAB74C8BC31Q51049449-A068B153-B4EB-49BB-91AA-F3EC44AE9B5BQ51496186-4382A4A7-F4B1-415C-8000-4B79F36AABA1Q52940095-3808636F-9100-48AF-AC17-4EE7DEB835E9
P2860
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@en
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@nl
type
label
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@en
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@nl
prefLabel
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@en
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@nl
P2093
P1476
Do polycystic-appearing ovarie ...... ith polycystic ovary syndrome?
@en
P2093
P304
P356
10.1016/S0015-0282(00)00695-6
P407
P577
2000-09-01T00:00:00Z